Literature DB >> 12544321

Rhabdomyolysis from cytochrome p-450 interaction of ketoconazole and simvastatin in prostate cancer.

Haruka Itakura1, David Vaughn, Daniel G Haller, Peter J O'Dwyer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12544321     DOI： 10.1097/01.ju.0000043761.61046.b0

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  5 in total

Review 1.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

2.  Risk management of simvastatin or atorvastatin interactions with CYP3A4 inhibitors.

Authors:  Espen Molden; Eva Skovlund; Pia Braathen
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

3.  Hepatitis and rhabdomyolysis in a patient with hormone refractory prostate cancer on ketoconazole and concurrent lovastatin therapy.

Authors:  C A Stein; Sanjay Goel; Reza Ghavamian
Journal:  Invest New Drugs       Date:  2007-01-11       Impact factor: 3.651

4.  City-wide electronic health records reveal gender and age biases in administration of known drug-drug interactions.

Authors:  Rion Brattig Correia; Luciana P de Araújo Kohler; Mauro M Mattos; Luis M Rocha
Journal:  NPJ Digit Med       Date:  2019-07-23

5.  Trends and variations in outpatient coprescribing of simvastatin or atorvastatin with potentially interacting drugs in Thailand.

Authors:  Thananan Rattanachotphanit; Chulaporn Limwattananon; Onanong Waleekhachonloet
Journal:  Ther Adv Drug Saf       Date:  2019-01-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.